GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genexine Inc (XKRX:095700) » Definitions » Sale Of Business

Genexine (XKRX:095700) Sale Of Business : ₩0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Genexine Sale Of Business?

Genexine's sale of business for the three months ended in Sep. 2024 was ₩0 Mil. It means Genexine gained ₩0 Mil from selling business. Genexine's sale of business for the trailing twelve months (TTM) ended in Sep. 2024 was ₩0 Mil.

Compared with last quarter (₩0 Mil in Jun. 2024 ), Genexine gained the same money from selling business in Sep. 2024 (₩0 Mil).


Genexine Sale Of Business Historical Data

The historical data trend for Genexine's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genexine Sale Of Business Chart

Genexine Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,148.63 1,617.32 - 433.75 19,300.00

Genexine Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Genexine Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genexine Sale Of Business Related Terms

Thank you for viewing the detailed overview of Genexine's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Genexine Business Description

Traded in Other Exchanges
N/A
Address
700 Daewangpangyo-ro, Gyeonggi-do, Korea Bio Park Building B, Bundang-gu, Seongnam-si, KOR, 13488
Genexine Inc is a clinical-stage biotechnology company. It is focused on the development and commercialization of immunotherapeutics and next-generation long-acting biologics. Its primary technologies are Therapeutic DNA vaccine technology and Hyfc platform. The company's product pipeline includes products such as GX-H9, GX-E2, GX-G3, GX-G6, and Papitrol-188 among others.

Genexine Headlines

No Headlines